Loading...
Metformin and cardiorenal outcomes in diabetes: A reappraisal
The guidance issued to the pharmaceutical industry by the US Food and Drug Administration in 2008 has led to the publication of a series of randomized, controlled cardiovascular outcomes trials with newer therapeutic classes of glucose‐lowering medications. Several of these trials, which evaluated t...
Saved in:
| Published in: | Diabetes Obes Metab |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Blackwell Publishing Ltd
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7317924/ https://ncbi.nlm.nih.gov/pubmed/32009286 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13984 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|